Kaleido Biosciences, Inc.
KLDO
$0.002
$0.00191,900.00%
OTC PK
| 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | |
|---|---|---|---|---|---|
| Net Income | -20.27M | -23.09M | -23.89M | -23.04M | -20.02M |
| Total Depreciation and Amortization | 604.00K | 594.00K | 583.00K | 577.00K | 563.00K |
| Total Amortization of Deferred Charges | 177.00K | 172.00K | 173.00K | 183.00K | 259.00K |
| Total Other Non-Cash Items | 1.59M | 2.01M | 2.37M | 4.42M | 2.79M |
| Change in Net Operating Assets | 740.00K | 4.43M | 680.00K | -6.11M | 5.11M |
| Cash from Operations | -17.16M | -15.88M | -20.08M | -23.97M | -11.30M |
| Capital Expenditure | -436.00K | -431.00K | -232.00K | -30.00K | -662.00K |
| Sale of Property, Plant, and Equipment | 438.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 2.00K | -431.00K | -232.00K | -30.00K | -662.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | 5.00K | 5.00K | 56.00K | 70.33M | 3.73M |
| Repurchase of Common Stock | -30.00K | -19.00K | -104.00K | -186.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -20.00K | -- | -79.00K |
| Cash from Financing | -25.00K | -14.00K | -68.00K | 70.14M | 3.65M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -17.18M | -16.32M | -20.38M | 46.14M | -8.31M |